U.S. federal trademark · Serial No. 76105834 · Reg. No. 001622042
monoclonal antibody therapeutic pharmaceuticals for use in the treatment of cancer, acquired immune deficiency syndrome (AIDS), and other infectious diseases, autoimmune diseases, and cardiovascular diseases
[ biochemicals; namely, monoclonal antibodies for in vitro or scientific research regarding cancer, acquired immune deficiency syndrome (AIDS), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ]
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.